LinkedInInstagram
Loading...
Home New2021-02-09T16:47:28+00:00

Lumiheal Therapeutics

LumiHeal® is a unique and proprietary technology utilizing fluorescence light energy (FLE) to stimulate the skin’s own biological processes and repair mechanisms without compromising patient safety or comfort. Lumiheal Therapeutics, Inc. was founded in 2020 to accelerate the development and deployment of LumiHeal® and the FLE platform for the treatment of acute and chronic wounds, surgical incisions and burns.

News & Events

September 26-28, 2019

The SICPRE Conference (Italian Society of Plastic Aesthetic and Reconstructive Surgery) – Palermo, Italy

September 23-25, 2019

The MedTech Conference – Boston, USA

August 30, 2019

Publication in Science Direct – Interest of photobiomodulation in the management of acute second-degree burns

August 19-22, 2019

Military Health System Research Symposium – Florida, USA

June 5-7, 2019

European Wound Management Association – Gothenburg, Sweden

May 3-4, 2019

The European Society of Lymphology Meeting – Brussels, Belgium

March 20-21, 2019

Medical Technology Enterprise Consortium – South Carolina, USA

March 15-17, 2019

La Chirurgia Estetica– Florence, Italy

March 8, 2019

Publication in the SPIE Photonics West 2019 Conference Proceedings – Management of all three phases of wound healing through the induction of fluorescence biomodulation using fluorescence light energy

March 7, 2019

LumiHeal was granted the Canadian Medical Device License (MDL) for “the management of post-surgical closed wounds and to help in the prevention of hypertrophic scars and post-surgical wound complications in patients 18 years and older”.

March 1, 2019

Fluorescence Biomodulation has been added to various sections in the Journal of Wound Care’s 2019 peer-reviewed International Consensus Document – Implementing TIMERS: the race against hard-to-heal wounds

February 2-7, 2019

SPIE Photonics West – San Francisco, USA

January 30, 2019

LumiHeal Newsletter – Updates On Our Lead Wound Care Product

January 20-22, 2019

Journées Cicatrisations – Paris, France

November 5-7, 2018

Wounds UK – Harrogate, UK

November 4, 2018

Publication in the peer-reviewed Journal of Wound Care – Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: The EUREKA trial

September 24-26, 2018

The MedTech Conference – Philadelphia, USA

September 12-14, 2018

The European Pressure Ulcer Advisory Panel – Rome, Italy

June 13-14, 2018

Wound Care from Innovations to Clinical Trials (WCICT) – Edinburgh, UK

May 9-11, 2018

The European Wound Management Association (EWMA) – Krakow, Poland

April 25-29, 2018

The Symposium on Advanced Wound Care Spring (SAWC) – North Carolina, USA

News Spotlight

Contact Us










    lumiheal logo

    CONTACT US
    United States:
    2130 Highland Avenue South
    Suite 321
    Birmingham, AL 35205
    Outside the United States:
    275 boul. Armand-Frappier.
    Laval, Québec, H7V 4A7
    © Copyright  Lumiheal Therapeutics Inc. and Klox Technologies, Inc. - All rights reserved. Trademarks appearing on this website are owned by Lumiheal Therapeutics, Inc. or licensed from Klox Technologies, Inc.
    Web support by Infomedia

    This website describes our product, LumiHeal®, which has not been approved or cleared by the FDA for sale and is considered an investigational device in the United States. LumiHeal® is approved for use in certain other countries including the European Union and Australia as detailed in the Regulatory Status section of this website.

     I Understand